Showing 141-160 of 294 for: EBMG evidence summaries > Infectious disease 
- Immunoglobulins for the prevention of hepatitis A
EBMG evidence summaries, 5-Aug-2009
Immunoglobulins may be effective in the prevention of hepatitis A.
- Impact of antimicrobial resistance on Helicobacter pylori eradication rates
EBMG evidence summaries, 6-Aug-2003
Both nitromidazole and clarithromycin resistance appear to drop the efficacy rates of triple therapy containing these drugs significantly (up to 50-60%).
- Indications for urine bacterial culture
EBMG evidence summaries, 20-Mar-2003
Urine test or bacterial culture might possibly not be indicated in uncomplicated cystitis, because the condition is benign and usuallly responds to a short course of antibiotics, alhough there is no evidence from controlled trials.
- Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing
EBMG evidence summaries, 28-Feb-2007
Inhaled corticosteroids are probably not effective in the prevention of post-bronchiolitic wheezing.
- Initial management strategies of dyspepsia
EBMG evidence summaries, 8-Dec-2005
Proton pump inhibitors are effective in the treatment of dyspepsia, even if patients with gastro-oesophageal reflux disease may not have been adequately excluded in the trials. Early investigation by endoscopy compared to test and treat strategy for H. py
- Insecticide-treated nets for preventing malaria in pregnancy
EBMG evidence summaries, 1-Feb-2010
Insecticide-treated nets are effective in reducing malaria infections, low birthweight babies, and faetal loss during pregnancy in endemic areas.
- Insectiside treated bednets and curtains for preventing malaria
EBMG evidence summaries, 29-Mar-2006
Insectiside-treated nets are effective in reducing childhood mortality and morbidity from malaria.
- Interferon and prevention of hepatocellular carcinoma in viral cirrhosis
EBMG evidence summaries, 5-Feb-2003
Interferon appears to have a slight preventive effect on hepatocellular carcinoma prevention in patients with HCV-related cirrhosis.
- Interferon and ribavirin vs. interferon alone in the re-treatment of chronic hepatitis C
EBMG evidence summaries, 5-Feb-2003
Combination therapy with interferon and higher-dose ribavirin (1 000 to 1 200 mg/day), for at least 24 weeks, appears to be more effective than interferon alone in the re-treatment of interferon non-responders. However, the response rates remain low (l
- Interferon as treatment for acute hepatitis C
EBMG evidence summaries, 1-Jan-2002
A short course of low-dose interferon administered to patients with acute hepatitis C is significantly more effective than no treatment in obtaining viral clearance and normal aminotransferases 12 months after stopping treatment, but data on clinically im
- Interferon for chronic hepatitis B in adults
EBMG evidence summaries, 1-Jan-2000
Interferon is effective in inducing remission in patients with chronic hepatitis B.
- Interferon for chronic hepatitis C
EBMG evidence summaries, 20-Jul-2006
Interferon treatment is effective in achieving viral clearance and improving liver biochemistry and histology in chronic hepatitis C. About 17% of the patients have sustained virologial response to interferon alpha.
- Interferon for hepatitis C related cirrhosis
EBMG evidence summaries, 5-Feb-2003
Interferon therapy appears to reduce the risk of hepatocellulare carcinoma in patients with hepatitis C virus (HCV) -related cirrhosis.
- Interferon-alpha therapy for chronic hepatitis B in children
EBMG evidence summaries, 6-Aug-2003
Interferon-alpha treatment of children with hepatitis B appears to result in clearance of hepatitis B virus in the short term, but data on clinically important outcomes do not exist.
- Intermittent dosing with drugs for tuberculosis
EBMG evidence summaries, 10-Nov-2006
Intermittent dosing of drugs three times a week is probably not as effective as daily dosing in the treatment of tuberculosis in adults.
- Interventions for cutaneous molluscum contagiosum
EBMG evidence summaries, 8-Dec-2009
There is insufficient evidence from controlled trials of the effectiveness of topical or systemic treatments for molluscum infection.
- Interventions for decreased bone mineral density associated with HIV infection
EBMG evidence summaries, 17-Aug-2007
Bisphosphonate therapy and testosterone in those with AIDS wasting syndrome may be safe and possibly effective methods to improve bone mineral density in HIV patients.
- Interventions for preventing ankle ligament injuries
EBMG evidence summaries, 20-Mar-2003
Ankle supports (semi-rigid orthoses or air-cast braces) are beneficial in preventing ankle ligament injuries during high-risk sports activities.
- Interventions for preventing injuries in problem drinkers
EBMG evidence summaries, 8-Aug-2006
Interventions like brief counseling for problem drinking may be effective for reducing injuries.
- Interventions for promoting smoking cessation during pregnancy
EBMG evidence summaries, 4-Mar-2010
Smoking cessation programs in pregnancy appear to reduce smoking, low birth weight and preterm birth, but no effect was detected for very low birth weight or perinatal mortality.
